This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Phase III Cat-PAD Follow-on Study
Clinical trial

Phase III Cat-PAD Follow-on Study

Read time: 1 mins
Last updated:17th Jan 2014

The purpose of this study is to evaluate the continued effectiveness and safety of Cat-PAD in cat allergic subjects for up to five years after the start of administration of treatment. The study is an optional follow-up study to a phase III double-blind, placebo controlled, Cat-PAD study; no further investigational product is administered.

Category Value
Study start date 2014-01-17

View full details